http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019191389-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4d859bb986cc53e418c0a94622e97b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2fb815dee18f748ab4b453fcc2fd0fb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-167
filingDate 2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10e8357da3c4dd7893c901a5146a8f8c
publicationDate 2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019191389-A1
titleOfInvention Solid-state forms of regadenoson, their use and preparation
abstract The invention relates to a crystalline methanol or dimethyl sulfoxide solvated form of regadenoson and an anhydrous polymorph of regadenoson. The invention is also directed to the preparation of the methanol or dimethyl sulfoxide solvated and anhydrous solid-state forms of regadenoson. In particular, the invention relates to the preparation of the anhydrous polymorph of regadenoson in a stable form from the dimethyl sulfoxide solvated form of regadenoson, which preparation is purifiable and scalable.
priorityDate 2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6642210-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014177119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016126734-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9441006-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2789624-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017042837-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016244474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014207758-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014068589-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9809617-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017002036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016024137-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859522-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9624258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085601-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226973662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID344245795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123618048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454463664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID219024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10129899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961

Total number of triples: 52.